Target intelligence / Profile preview

Snake venom three-finger neurotoxin (3FTx)

Target
3FTx
Molecular classification
Snake venom toxin, Three-finger toxin family, Non-enzymatic protein
01

Overview

Snake venom three-finger neurotoxins (3FTxs) are a major family of non-enzymatic proteins found in the venom of elapid snakes, including the Indian Cobra (Naja naja) and Common Krait (Bungarus caeruleus). These toxins are characterized by a conserved structural scaffold consisting of three beta-stranded loops projecting from a central hydrophobic core, resembling three fingers of a hand. Their primary biological function is to induce paralysis by binding with high affinity to nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction, thereby blocking cholinergic transmission. In the context of Indian elapid envenomation, 3FTxs are the principal drivers of life-threatening neurotoxicity and respiratory failure. Therapeutic intervention primarily involves the administration of polyvalent antivenoms, which contain antibodies that neutralize these toxins. Recent advancements include the development of synthetic human antibodies, such as 95Mat5, which target conserved regions of the 3FTx family to provide broad-spectrum protection against diverse elapid venoms.

Other names
Three-finger toxin3FTxα-neurotoxinPost-synaptic neurotoxinCuraremimetic toxinSnake venom three-finger toxin
02

Mechanism of action

Neutralization of the toxin's ability to bind to host receptors, such as the nicotinic acetylcholine receptor (nAChR), by antibody-mediated sequestration or competitive inhibition of the toxin's functional loops.

03

Biological functions

Neuromuscular blockadeNicotinic acetylcholine receptor antagonismMuscarinic receptor antagonismIon channel modulationCell lysis
04

Disease associations

Snakebite envenomationParalysisRespiratory failureDermonecrosis
05

Safety considerations

Anaphylaxis (associated with equine-derived antivenom)Serum sicknessRapid onset of paralysis requiring mechanical ventilationGeographic variation in venom composition affecting antivenom efficacy
06

Interacting drugs

Polyvalent antivenom

1 more in the full profile.

07

Biomarkers

Venom antigen (ELISA)PtosisRespiratory distressNeuromuscular weakness

Beyond the preview

Go deeper on Snake venom three-finger neurotoxin (3FTx).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Snake venom three-finger neurotoxin (3FTx).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call